Lake-Bakaar Gerond, Ahmed Muneeb, Evenson Amy, Bonder Alan, Faintuch Salomao, Sundaram Vinay
Liver Tumor Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass., USA.
Liver Cancer. 2014 Oct;3(3-4):428-38. doi: 10.1159/000343871.
Hepatic decompensation in cirrhosis heralds an accelerated course with poor survival. An increase in hepatic venous pressure gradient (HVPG), rather than surrogate tests of liver function, appears to be the sole predictor of decompensation after surgical resection. We propose that hepatic sinusoidal walls become less elastic as cirrhosis progresses. Decompensation signals the development of increased vessel wall rigidity. The pressure-flow characteristics then become subject to Hagen-Poiseuille's law, which applies only to rigid, cylindrical vessels. Thereafter, HVPG rises exponentially (by a factor inversely proportional to the fourth power of the net radius of functional sinusoidal vessels, 1/r(4), at any given hepatic blood flow rate. This review attempts to correlate liver stiffness, risk of decompensation and outcomes from hepatocellular carcinoma (HCC) in patients with cirrhosis.
We compare the complexity of autoregulation in the normal elastic liver, which has a unique dual blood supply, with that in the rigid cirrhotic liver. We also review, in the context of background liver cirrhosis, the management of HCC which is in essence, a solid mass of unorganized cells that exacerbates liver stiffness. We discuss the differential effects of various therapeutic modalities such as liver transplantation, loco-regional therapy and drugs on HCC outcomes, based on their effects on HVPG.
Increased hepatic artery supply, or the hepatic artery buffer response, may be the only available method for autoregulation or maintenance of hepatic blood flow in the cirrhotic liver. In HCC, loco-regional therapies, including partial resection of the cirrhotic liver, can exacerbate portal hypertension by increasing blood flow within the remnant organ. We conclude that studies of HVPG reduction as part of HCC management may be beneficial and are warranted.
肝硬化患者出现肝失代偿预示病程加速,生存率降低。肝静脉压力梯度(HVPG)升高而非肝功能替代检测似乎是手术切除后失代偿的唯一预测指标。我们提出,随着肝硬化进展,肝窦壁弹性降低。失代偿标志着血管壁硬度增加。压力 - 流量特性随后遵循哈根 - 泊肃叶定律,该定律仅适用于刚性圆柱形血管。此后,在任何给定肝血流速率下,HVPG呈指数上升(上升因子与功能性肝窦血管净半径的四次方成反比,即1/r⁴)。本综述旨在关联肝硬化患者的肝脏硬度、失代偿风险及肝细胞癌(HCC)的预后。
我们比较了具有独特双重血液供应的正常弹性肝脏与刚性肝硬化肝脏中自动调节的复杂性。我们还在背景肝硬化的背景下,综述了HCC的管理,HCC本质上是一团无序细胞组成的实体,会加剧肝脏硬度。我们基于各种治疗方式对HVPG的影响,讨论了肝移植、局部区域治疗和药物等不同治疗方式对HCC预后的差异影响。
肝动脉供应增加或肝动脉缓冲反应可能是肝硬化肝脏中自动调节或维持肝血流的唯一可用方法。在HCC中,包括肝硬化肝脏部分切除在内的局部区域治疗可通过增加残余器官内的血流而加重门静脉高压。我们得出结论,作为HCC管理一部分的降低HVPG的研究可能有益且有必要。